Is Trastuzumab Deruxtecan Effective in ERBB2-Mutant NSCLC?

Trastuzumab deruxtecan monotherapy shows systemic as well as intracranial effectiveness in patients with previously treated ERBB2-mutant NSCLC.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/trastuzumab-deruxtecan-effective-erbb2-mutant-nsclc-2025a1000vv4?src=rss

Author :

Publish date : 2025-11-17 09:30:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Is Trastuzumab Deruxtecan Effective in ERBB2-Mutant NSCLC?

No Time to Die: Is Well-Being the Elixir for Healthy Aging?

Measles and Hand-Foot-Mouth Disease Rates Climbing

Related Posts

EU Clears Path for Biosimilars in Diabetes & Bone Health

Online Tool Estimates Percentiles for Long-Term Cardiovascular Risk

European Regulator Greenlights New Pertussis Vaccine

Gemini Leads LLMs in Communicating AMR Health Advice

Short-Bowel Syndrome Treatment Nears Approval in EU

Frailty Program Cuts Costs, Boosts Health of Older Adults

EU Clears Path for Biosimilars in Diabetes & Bone Health

Online Tool Estimates Percentiles for Long-Term Cardiovascular Risk

European Regulator Greenlights New Pertussis Vaccine

Gemini Leads LLMs in Communicating AMR Health Advice

Short-Bowel Syndrome Treatment Nears Approval in EU

Frailty Program Cuts Costs, Boosts Health of Older Adults

Measles and Hand-Foot-Mouth Disease Rates Climbing

Is Trastuzumab Deruxtecan Effective in ERBB2-Mutant NSCLC?

Categories

Archives